{"id":"e2293b6d-1701-4b2b-b783-605ccefd625a","arxiv_id":"2507.00597","paper_version":1,"verdict":"REJECT","confidence":"LOW","novelty_score":6.0,"correctness_risk":"high","formal_verification":"none","parameter_count":2,"one_line_summary":"Simulations show that RSA reduces viscoelastic power dissipation in pulmonary arterioles during mode-locked cardiorespiratory synchronization, matching a 17-20% gain in cardiac output seen in animal trials.","lead":"This paper claims that respiratory sinus arrhythmia, the natural variation of heart rate with breathing, reduces energy lost in the blood vessels around the lungs, improving cardiac output in heart failure. The authors say this explains the 17-20% increase in cardiac output seen in animals paced with their neural pacemaker device.","discovery_kind":"new_application","skeptic_critique":{"model":"deepseek-v4-flash","headline":"The 19% agreement with animal data requires an unstated mapping from viscoelastic power saving to cardiac output; absent that, the match cannot be distinguished from coincidence.","rationale":"The paper's premise is interesting: RSA may improve cardiac efficiency by synchronizing cardiac and respiratory rhythms to reduce viscoelastic losses in pulmonary arterioles. The observation that power savings appear in Arnold tongues is qualitatively plausible, and the general claim that low heart rates benefit from RSA aligns with clinical findings. However, the paper's central quantitative validation—the 19% simulated power saving versus the 17-20% animal cardiac output increase—is uninterpretable without an explicit coupling between the computed dissipation ratio and cardiac output. The reader's verdict of rejection is warranted on these grounds. I do not find a different or stronger objection; the missing derivation is the same load-bearing flaw. The test I propose—recomputing the output gain from the power-saving map via a standard cardiovascular coupling model—would directly settle whether the agreement is real or coincidental. If the authors can provide this mapping and the viscoelastic model equations, the paper could become testable. But as written, the central claim is unfalsifiable because the path from Fig. 3 to the animal data is not specified. Hence I agree with the reader's assessment and see no reason to alter the verdict.","tokens_in":3384,"tokens_out":5141,"duration_ms":58922,"concrete_test":"Derive the predicted cardiac output gain from the reported power-saving map in Fig. 3 using a standard ventricular-vascular coupling model (e.g., a two-element Windkessel with Frank-Starling afterload dependence). If the predicted gain does not fall in the 17-20% range without introducing a free scaling parameter, the agreement claim in Section IV is unsupported.","verdict_should_be":"UNCHANGED","load_bearing_attack":"The quantitative core of the paper is the claim that computed viscoelastic power savings (25% in the 1:1 band, 19% in the 3:1 band) translate into the 17-20% cardiac output increase seen in RSA-paced animal trials. But the paper never specifies how a reduction in dissipated power becomes an increase in cardiac output. Cardiac output is a flow (stroke volume × heart rate); viscoelastic power dissipation is an energy rate. Bridging them requires a model of ventricular-vascular coupling (e.g., how reduced arteriolar impedance alters stroke volume via the Frank-Starling mechanism or effective arterial elastance), including numerical values for ventricular contractility, systemic resistance, and compliance. Section IV simply asserts 'energy gains of 19% in the 3:1 mode are in good agreement with the 17-20% increase in cardiac output' without derivation. The same gap applies to the 25% figure. Without this mapping, the reported agreement is not a test of the hypothesis; any computed saving in a hemodynamic proxy could be quoted. The absence of the dissipation model equations only deepens the problem: even the 25%/19% figures cannot be independently reproduced. The load-bearing assumption is therefore the implied equivalence between power saving and output gain, which is neither stated nor justified.","agreement_with_reader":"agree"},"referee_report":{"model":"deepseek-v4-flash","summary":"The paper claims that respiratory sinus arrhythmia (RSA) reduces viscoelastic power dissipation in the pulmonary arterioles when the cardiac and respiratory rhythms are mode-locked. The central numerical results are savings of up to 25% in the 1:1 Arnold tongue and 19% in the 3:1 tongue, a saturation of the benefit once RSA amplitude reaches 50%, and an optimal inspiratory-to-expiratory cardiac frequency ratio of about 1.5. The authors further assert that the simulated 19% power saving in the 3:1 mode agrees with the 17–20% increase in cardiac output observed in their RSA-paced animal trials, and that the effect is strongest at low heart rates, matching clinical observations.","tokens_in":3753,"tokens_out":3804,"duration_ms":44775,"significance":"If the quantitative claims were supported by a complete, reproducible model, the paper would offer a mechanistic explanation for the clinical benefit of restoring RSA in heart failure and would strengthen the rationale for the neural pacemaker. The choice of an external benchmark (the 17–20% increase in cardiac output from animal trials) is a sound non-circular validation strategy, and the predicted plateau and optimal frequency ratio are falsifiable predictions that could guide future experiments. However, the manuscript does not disclose the model equations, parameters, simulation methods, or the mapping between power dissipation and cardiac output, so the numerical predictions cannot currently be verified or reproduced. The strengths are therefore largely prospective: the scientific question is important and the qualitative synchronization framework is appropriate, but the evidence presented is not sufficient to establish the stated quantitative conclusions.","major_comments":[{"comment":"The central quantitative results — 25% power saving in the 1:1 band, 19% in the 3:1 band, the plateau at 50% RSA amplitude, and the optimal frequency ratio of 1.5 — are presented without the underlying model. The manuscript nowhere states the constitutive equation for viscoelastic dissipation, the vessel geometry and material parameters, the pressure waveform, or the numerical methods used. Without these, none of the numerical values can be independently reproduced, and the abstract's principal claims are not verifiable. The authors should provide the full model equations and a parameter table, either in the text or in a supplementary document.","section":"Section III, Fig. 3"},{"comment":"The sentence 'energy gains of 19% in the 3:1 mode are in good agreement with the 17-20% increase in cardiac output' asserts an unexplained equivalence between a reduction in viscoelastic power dissipation and an increase in cardiac output. Cardiac output is a flow (stroke volume times heart rate), whereas dissipated power is an energy rate; bridging these quantities requires an explicit hemodynamic coupling model (e.g., effective arterial elastance, ventricular-vascular coupling, or a Frank-Starling mechanism) with numerical values. Until this mapping is specified and justified, the 19%-versus-17-20% agreement cannot be distinguished from coincidence and does not test the hypothesis.","section":"Section IV"},{"comment":"The variables f_Heart and f_Resp are used in the colour map but are not formally defined in the text, and 'RSA amplitude' is invoked in the claim that gains saturate at 50% without giving the amplitude's definition or showing supporting data. Please define all control parameters and provide the saturation curve or a quantitative criterion for the plateau.","section":"Section III, caption of Fig. 3"},{"comment":"The method section describes the biological circuit and the pacemaker but not the simulation used to generate Fig. 3. It is unclear whether the power computation is a closed-form analytic expression, a numerical integration of differential equations, or a Monte Carlo simulation, and what inputs (e.g., heart-rate time series, lung-volume signal, vessel pressure waveform) are used. This omission affects even the qualitative Arnold tongue map, since the synchronization boundaries presumably depend on the model of the central pattern generator. Please add a complete simulation description, including equations and parameter values.","section":"Section II"}],"minor_comments":[{"comment":"The phrase 'breadth intake' appears to be a typographical error and should read 'breath intake'.","section":"Abstract and Section I"},{"comment":"The word 'agrement' is a typo and should read 'agreement'.","section":"Section IV"},{"comment":"The symbols f_Heart and f_Resp are introduced in the caption but are not listed in a nomenclature or defined in the main text; please define all symbols and use consistent subscript formatting.","section":"Fig. 3 caption"},{"comment":"The 'typical RSA dose of 13%' is defined as a ratio of cardiac frequencies, but the abstract's 'magnitude of RSA' and the 50% amplitude mentioned in Fig. 3 are not tied to this dose; please unify the terminology and define the dose metric explicitly.","section":"Section II"},{"comment":"The reference list contains formatting errors, including 'PHys.Rev. E' in [7] and inconsistent use of italics and page ranges; the authors should harmonize the reference style.","section":"References"}],"recommendation":"major_revision","confidential_remarks":"The manuscript reads like an IEEE conference proceedings paper, and the journal version would need substantially more methodological content. The central question is important and the external benchmark comparison is well chosen, but the lack of model disclosure is the primary obstacle. I recommend major revision rather than rejection because the omissions, though serious, are in principle addressable by adding derivations, parameter tables, and an explicit power-to-cardiac-output mapping."},"author_rebuttal":null,"desk_editor":{"model":"deepseek-v4-flash","letter":"Josh, read this one. The idea is worth five minutes: RSA reduces viscoelastic dissipation in pulmonary arterioles by mode-locking, and that might explain the 17–20% cardiac output gain from the Bath pacemaker. That's a new and interesting hypothesis. But the paper as written is a claim without a derivation. The 25% and 19% power savings, the 50% amplitude saturation, and the optimal ratio of 1.5 all come out of a simulation that is described only verbally. No equations, no parameter values, no code, no data. You can't reproduce the numbers, and you can't tell whether the agreement with the animal data is a prediction or a fit.\n\nWhat the paper does well: the normalization to mean heart rate is careful; the Arnold tongue framing is appropriate for coupled oscillators; and using the pacemaker to vary RSA amplitude is a genuinely nice experimental handle. The 3:1 mode being the relevant one for mammals is plausible, and the low heart rate rest effect matches clinical observation.\n\nThe soft spots are not minor. The biggest gap is the mapping from viscoelastic power saved to cardiac output gained. These are different quantities. To bridge them you need a ventricular-vascular coupling model—how a change in arteriolar impedance moves stroke volume through Frank-Starling or effective arterial elastance. Section IV just asserts 'energy gains of 19% are in good agreement with the 17–20% increase in cardiac output.' That is not a derivation. If the authors have this mapping, it needs to be laid out with numbers. Without it, the 19% match is as good as coincidence.\n\nThere are also smaller issues: typos ('breadth intake', 'agrement'), the unsupported claim that 3:1 is the relevant ratio for mammals, and the 50% saturation figure appearing only in the figure caption.\n\nOn a scale: I'd give the idea a real chance. The physiology is plausible and the experimental benchmark is external. But the paper as it stands is not checkable. For peer review, I'd send it out with a request for major revision: full model equations, parameters, validation against other hemodynamic measurements, and an explicit ventricular-vascular coupling step. If those are supplied, this could be a solid contribution. If not, the agreement claim should not be taken seriously.\n\nRecommendation: don't desk reject on plausibility; send it to reviewers who can push for the model disclosure. Worth a reading-group slot as a case study in how the absence of methods undermines a plausible result.","headline":"Plausible mechanism for RSA benefit, but the quantitative claims rest on an undisclosed simulation and an unstated power-to-output mapping.","tokens_in":4134,"tokens_out":3467,"would_cite":false,"duration_ms":34189,"reading_group":"yes","serious_thinker":"yes","would_accept_peer_review":true},"rs_alignment":null,"lean_confirmation":null,"pith_extraction":{"msc":[],"pacs":[],"model":"deepseek-v4-flash","headline":"Respiratory sinus arrhythmia cuts cardiac power loss up to 25% via heartbeat–breathing lock","keywords":["respiratory sinus arrhythmia","cardiorespiratory synchronization","Arnold tongues","neuronal pacemaker","heart failure","cardiac output","viscoelastic dissipation","central pattern generator"],"falsifier":"Measure cardiac output and the mechanical work done on lung arterioles in the same animal while sweeping the RSA dose from 0% to 50% and crossing the 3:1 synchronization band; the claimed mechanism predicts the efficiency gain appears only inside the locked band and tracks dissipated power. Alternatively, recovering the paper's dissipation curve from published pulmonary arteriole impedance data would settle whether the 19% saving is real.","tokens_in":3172,"feed_emoji":"🫀","tokens_out":5229,"duration_ms":56138,"temperature":0.7,"pith_summary":"This paper argues that respiratory sinus arrhythmia (RSA) — the natural speeding up of the heart during inspiration and slowing during expiration — is not a side effect of breathing but an energy-saving mechanism. Simulating a neural pacemaker that restores RSA in heart failure, the authors find that when cardiac and respiratory rhythms lock into integer ratios, viscoelastic energy lost in stretched lung arterioles falls by up to 25%. The predicted power saving in the 3:1 lock, about 19%, matches the 17–20% rise in cardiac output measured in paced rats, sheep, and pigs. If the mechanism is right, restoring RSA is not just restoring variability; it is restoring efficient cardiac pumping.","feed_headline":"Breathing–heart locking cuts wasted cardiac power by up to 25%","feed_subtitle":"Mode-locked synchronization explains the 17–20% cardiac output gain seen in RSA-paced heart failure models.","key_machinery":"The central object is the Arnold tongue: a region in parameter space where $m$ cardiac intervals exactly span $n$ respiratory cycles, such as 1:1, 3:2, 2:1, or 3:1. These tongues form because the respiratory central pattern generator's nonlinear neurons bias the vagal modulation of heart rate toward commensurate frequency ratios. Inside a tongue, the timing of cardiac contractions relative to breathing becomes periodic, and the authors' model attributes lower viscoelastic dissipation to these locked states. The dissipation is computed in pulmonary alveolar arterioles, whose periodic stretch under inhalation and systolic pressure is taken as the main impedance load on the heart.","core_discovery":"The central claim is that RSA reduces the viscoelastic power the heart wastes on the arterioles surrounding pulmonary alveoli, and that this reduction happens inside mode-locked synchronization regions. Using a silicon model of the brainstem central pattern generator to generate cardiac pulse timings, the authors compute dissipated power with RSA normalized to the same mean heart rate without RSA. They report savings up to 25% in the 1:1 Arnold tongue and 19% in the 3:1 tongue, with the benefit largest at low cardiac frequencies and saturating once RSA amplitude reaches about 50%. They conclude that this energy saving quantitatively explains the 17–20% cardiac output increase observed in animal models with restored RSA.","pith_inferences":["By the paper's logic, any intervention that increases cardiorespiratory synchronization — not only a neural pacemaker — should improve cardiac efficiency; this could be tested with vagal or respiratory pacing protocols.","The undisclosed viscoelastic dissipation model is the pivot: publishing its equations would let others test whether alveolar arterioles are indeed the dominant impedance, or whether other vessels contribute comparably.","A testable extension would measure cardiac output across a continuous RSA dose in one animal model and compare the dose–response curve to the Arnold-tongue map, which predicts efficiency gains that appear only inside locked bands.","If the power-saving interpretation is correct, the benefit of RSA should weaken when breathing is too irregular to support phase locking, a prediction that could be checked in patients with irregular breathing patterns."],"forward_implications":["If RSA saves cardiac power through synchronization, then artificial pacemakers that restore RSA may improve pumping efficiency without raising mean heart rate.","The plateau near a 1.5-fold inspiratory-to-expiratory cardiac frequency ratio defines a dosing target for neural pacemakers; stronger RSA beyond that point buys no extra efficiency.","RSA should matter most at low cardiac frequencies, matching the clinical picture of benefit mainly at rest.","The 3:1 band, the ratio most relevant to mammals, predicts a 19% efficiency gain, the same size as the observed cardiac output increase in animal heart-failure models.","Energy accounting of this kind could turn heart-rate-variability restoration into a quantitative design criterion rather than an empirical endpoint."],"supporting_citations":[{"why":"Supplies the large-animal heart-failure trial data reporting increased cardiac output with restored RSA that the simulation is compared against.","marker":"[11]"},{"why":"Gives the rat left-ventricular-dysfunction data showing RSA-enhanced cardiac output, providing the 17–20% experimental benchmark.","marker":"[12]"},{"why":"Reports increased cardiac output and left ventricular contractility in pigs paced with restored RSA, extending the animal-model evidence.","marker":"[13]"},{"why":"Documents synchronization in the human cardiorespiratory system, providing empirical basis for the mode-locking picture.","marker":"[6]"},{"why":"Maps regions of cardiorespiratory synchronization under paced respiration, supporting the Arnold-tongue interpretation.","marker":"[7]"},{"why":"Introduces the central pattern generator hardware whose modeled pulse timings are used in the power-dissipation calculation.","marker":"[10]"}],"fun_headline_variants":["Breathing-heart mode-lock saves up to 25% cardiac power","RSA reduces wasted heart power via mode-locking","Cardiac efficiency gains from cardiorespiratory coupling","Heart failure: RSA pacing trims energy waste 25%"],"cache_read_input_tokens":3200,"weakest_assumption_plain":"Everything hangs on an unpublished model of how much energy is lost when the small blood vessels around lung air sacs stretch, and on the assumption that a one-percent drop in that lost energy directly becomes a one-percent rise in cardiac output; if either link is wrong, the match with the experimental 17–20% gain does not follow.","fun_headline_variants_meta":{"raw":{"variants":["Breathing-heart mode-lock saves up to 25% cardiac power","RSA reduces wasted heart power via mode-locking","Cardiac efficiency gains from cardiorespiratory coupling","Heart failure: RSA pacing trims energy waste 25%"]},"model":"deepseek-v4-flash","effort":"low","cost_usd":0.000551,"raw_usage":{"total_tokens":2596,"prompt_tokens":883,"completion_tokens":1713,"prompt_tokens_details":{"cached_tokens":384},"prompt_cache_hit_tokens":384,"prompt_cache_miss_tokens":499,"completion_tokens_details":{"reasoning_tokens":1643}},"tokens_in":499,"tokens_out":1713,"duration_ms":14137,"temperature":1.0,"reasoning_tokens":1643,"cache_read_input_tokens":384,"cache_creation_input_tokens":0},"cache_creation_input_tokens":0},"created_at":"2026-08-06T21:11:22.922592+00:00","model_set":{"reader":"deepseek-v4-flash"},"falsifier":"Measure cardiac output and the mechanical work done on lung arterioles in the same animal while sweeping the RSA dose from 0% to 50% and crossing the 3:1 synchronization band; the claimed mechanism predicts the efficiency gain appears only inside the locked band and tracks dissipated power. Alternatively, recovering the paper's dissipation curve from published pulmonary arteriole impedance data would settle whether the 19% saving is real.","supporting_citations":[{"cited_title":"Reverse re-modelling chronic heart failure by reinstat- ing heart rate variability,","cited_arxiv_id":null,"evidence_quote":"Supplies the large-animal heart-failure trial data reporting increased cardiac output with restored RSA that the simulation is compared against."},{"cited_title":"Enhancing respiratory sinus arrhythmia increases cardiac output in rats with left ventricular dysfunction,","cited_arxiv_id":null,"evidence_quote":"Gives the rat left-ventricular-dysfunction data showing RSA-enhanced cardiac output, providing the 17–20% experimental benchmark."},{"cited_title":"Increased cardiac output and left ventricular contractility in pigs paced with vs. without restored respiratory sinus arrhythmia,","cited_arxiv_id":null,"evidence_quote":"Reports increased cardiac output and left ventricular contractility in pigs paced with restored RSA, extending the animal-model evidence."},{"cited_title":"Synchronization in the human cardiorespiratory system,","cited_arxiv_id":null,"evidence_quote":"Documents synchronization in the human cardiorespiratory system, providing empirical basis for the mode-locking picture."},{"cited_title":"Regions of cardiorespiratory synchronization in humans under paced respiration,","cited_arxiv_id":null,"evidence_quote":"Maps regions of cardiorespiratory synchronization under paced respiration, supporting the Arnold-tongue interpretation."},{"cited_title":"Modulation of respiratory sinus arrhythmia in rats with central pattern generator hardware,","cited_arxiv_id":null,"evidence_quote":"Introduces the central pattern generator hardware whose modeled pulse timings are used in the power-dissipation calculation."}],"review_version":1}